Personal profile

Biography

Professor Morand is Head of the School of Clinical Sciences at Monash Health, Monash University's largest clinical school.

He is a specialist rheumatologist, and Head of the Monash Health Rheumatology Unit, the largest in Australia. He specalises in research and clinical care of systemic lupus erythematosus, as well as complex rheumatic diseases and rheumatoid arthriitis. He is founder of the Monash Lupus Clinic, Australia's largest Lupus-focussed research-grounded clinic for patients with SLE, a founding member of the Australian Lupus Registry &  Biobank, and Chair of the AsiaPaciifc Lupus Collaboration. 

Consulting

Consulting and research collaboration experience with international biotech and Pharma companies including AstraZeneca, Janssen, BMS, UCB, Pfizer, Eli Lilly, GSK, CSL.

 

Special interests include SLE outcome measures, trials, translational research and biomarkers. 

Research interests

Professor Morand's is a physician-scientist whose key interests are clinical outcome measurement and biological profiling in SLE, and the actions of glucocorticoid induced proteins on the immune system. 

His group has pioneered the development of treat-to-target outcome measures in SLE, via the AsiaPacific Lupus Collaboration, which has over 1800 patients under study. 

Biomarker studies in SLE are also a major interest ,with 000s of samples linked to longitudinal clincial data archived in the Australian Lupus Registry & Biobank, headquartered at Monash. 

His lab group discovered the role in rheumatic disease of four glucocorticoid-regulated proteins. Most recently his group defined the role of GILZ in RA, Th17 pathways, B cell activation, and lupus, and are working on exploting its actions to develop a safe glucocortioid mimic. 

Clinical activities

Professor Morand is Head of Rheumatology, Monash Health. 

Community service

Professor Morand has served on the board of the Australian Rheumatology Association and is a member of the Scientific Advisory Board of its Research Trust. 

Keywords

  • Systemic Lupus Erythematosus
  • glucocorticoids
  • Lupus
  • SLE
  • RA
  • GILZ
  • MIF
  • Rheumatoid Arthritis

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2000 2105

Research Output 1996 2018

Discordance of patient and physician health status concerns in systemic lupus erythematosus

Golder, V., Ooi, J. J. Y., Antony, A. S., Ko, T., Morton, S., Kandane-Rathnayake, R., Morand, E. F. & Hoi, A. Y. 1 Mar 2018 In : Lupus. 27, 3, p. 501-506 6 p.

Research output: Research - peer-reviewArticle

Longitudinal association of type 1 interferon-induced chemokines with disease activity in systemic lupus erythematosus

Connelly, K. L., Kandane-Rathnayake, R., Huq, M., Hoi, A., Nikpour, M. & Morand, E. F. 1 Dec 2018 In : Scientific Reports. 8, 1, 9 p., 3268

Research output: Research - peer-reviewArticle

Open Access
File

A framework for remission in SLE: Consensus findings from a large international task force on definitions of remission in SLE (DORIS)

van Vollenhoven, R. , Voskuyl, A. , Bertsias, G. , Aranow, C. , Aringer, M. , Arnaud, L. , Askanase, A. , Balážová, P. , Bonfa, E. , Bootsma, H. , Boumpas, D. , Bruce, I. , Cervera, R. , Clarke, A. , Coney, C. , Costedoat-Chalumeau, N. , Czirják, L. , Derksen, R. , Doria, A. , Dörner, T. & 38 others Fischer-Betz, R., Fritsch-Stork, R., Gordon, C., Graninger, W., Györi, N., Houssiau, F., Isenberg, D., Jacobsen, S., Jayne, D., Kuhn, A., Guern, V. L., Lerstrøm, K., Levy, R., Machado-Ribeiro, F., Mariette, X., Missaykeh, J., Morand, E., Mosca, M., Inanc, M., Navarra, S., Neumann, I., Olesinska, M., Petri, M., Rahman, A., Rekvig, O. P., Rovensky, J., Shoenfeld, Y., Smolen, J., Tincani, A., Urowitz, M., van Leeuw, B., Vasconcelos, C., Voss, A., Werth, V. P., Zakharova, H., Zoma, A., Schneider, M. & Ward, M. 1 Mar 2017 In : Annals of the Rheumatic Diseases. 76, 3, p. 554-561

Research output: Research - peer-reviewArticle

Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study

Golder, V. , Kandane-Rathnayake, R. , Hoi, A. Y-B. , Huq, M. , Louthrenoo, W. , An, Y. , Li, Z. G. , Luo, S. F. , Sockalingam, S. , Lau, C. S. , Mok, M. Y. , Lateef, A. , Franklyn, K. , Morton, S. , Navarra, S. T. V. , Zamora, L. , Wu, Y. J. , Hamijoyo, L. , Chan, M. , O'Neill, S. & 3 others Goldblatt, F., Nikpour, M. & Morand, E. F. 20 Mar 2017 In : Arthritis Research and Therapy. 19, 1, 11 p., 62

Research output: Research - peer-reviewArticle

Open Access
File
Open Access
File

Prizes

Distinguished Innovator Award

Eric Francis Morand (Recipient), 2015

Prize: National/international honour

Parr Prize for Research

Eric Francis Morand (Recipient), 2001

Prize: Prize (including medals and awards)

Supervisor of the Year

Eric Francis Morand (Recipient), 2011

Prize: Prize (including medals and awards)